Aaron Diamond Center for AIDS Research - Dec., p. 362
Aastrom Biosciences, Inc. - Nov., p. 330
Abbott Labs. - Feb., p. 38; Mar., p. 72; Apr., p. 103; July, p. 193; Oct., p. 290, 298; Dec., p. 364
Advanced BioScience Labs., Inc. - Nov., p. 333
Advanced Medical Sciences, Inc. - Apr., p. 105
Advanced Peptides Inc. - Nov., p. 329
Advanced Viral Research Corp. - Feb., p. 43
Advisory Committee on Immunization Practices (ACIP) - Feb., p. 43; July, p. 204; Aug., p. 236
AEA Technology - Apr., p. 99
Affymax Research Inst. - Sep., p. 268
Agence Nationale de Recherches sur de le Sida (ANRS) - July, p. 196
Agouron Pharmaceuticals, Inc. - Feb., p. 37; Mar., p. 72; May, p. 137; Aug., p. 232; Sep., p. 266; Oct., p. 298
AIDS Clinical Trials Group (ACTG) - Oct., p. 300; Dec., p. 364
AIDS Research Advisory Committee (ARAC) - June, p. 172
Ajinomoto Co., Inc. - Sep., p. 270
Akzo Nobel Pharma - Nov., p. 333; Dec., p. 366
Allelix Biopharmaceuticals Inc. - Feb., p. 40; Oct., p. 299
Alpha 1 Biomedicals, Inc. - Feb., p. 41; Apr., p. 102; May, p. 140; Aug., p. 235; Oct., p. 299
American Academy of Pediatrics - Mar., p. 65; Apr., p. 104
American Council of Life Insurance - Sep., p. 266
American Home Products Corp. - Apr., p. 100, 109; July, p. 200; Sep., p. 262; Nov., p. 327, 329; Dec., p. 361
American National Red Cross - Nov., p. 331
Amgen Corp. - May, p. 136; Aug., p. 233; Nov., p. 330
Anabolics for AIDS - June, p. 171
Aperture Associates - Feb., p. 41
Apollon, Inc. - Aug., p. 231; Dec., p. 361
Applied Immune Sciences, Inc. - Nov., p. 330
Argus Pharmaceuticals, Inc. - Mar., p. 75
Armed Forces Research Inst. of Medical Sciences - Nov., p. 332
Aronex Pharmaceuticals Inc. - Nov., p. 325, 333; Dec., p. 364
Astra USA, Inc. - July, p. 193; Sep., p. 266
Avid Therapeutics Inc. - Apr., p. 109
Aviron, Inc. - Apr., p. 108; May, p. 135; Dec., p. 363
Baker Norton Pharmaceuticals - Feb., p. 42
Barr Labs. - Apr., p. 105; June, p. 173
Baxter Healthcare Corp. - June, p. 168
Bayer AG - Nov., p. 328
Bayer Corp. - Oct., p. 295
Becton Dickinson & Co. - Nov., p. 332
Beth Israel Hospital - Sep., p. 268
BIKEN Institute - Mar., p. 65
BioChem Pharma Inc. - Feb., p. 35; Aug., p. 227; Sep., p. 262, 265; Nov., p. 321, 326
Biocontrol Technology, Inc. - May, p. 138
Biocor-Arm - Feb., p. 43
BioCryst Pharmaceuticals, Inc. - Feb., p. 41
Biogen Inc. - Feb., p. 46; Apr., p. 104, 109; May, p. 135
Biotech Research Labs. - Nov., p. 333; Dec., p. 364
Biotechnology Industry Organization - Feb., p. 45
Biotechnology Investments Ltd. - Feb., p. 41
Bock Pharmacal Co. - Apr., p. 105
Boehringer Ingelheim GmbH - Apr., p. 103
Boehringer Mannheim GmbH - Feb., p. 38; Mar., p. 77; Sep., p. 263; Nov., p. 327
Bristol-Myers Squibb Co. - Mar., p. 76; May, p. 130; June, p. 168; Aug., p. 236; Sep., p. 257, 263; Oct., p. 289; Nov., p. 331
British Biotech Pharmaceuticals - July, p. 197
British High Court of Appeals - Dec., p. 366
Burroughs Wellcome Co. (see also Glaxo Wellcome and Wellcome entries) - Feb., p. 35, 36, 40
Cambridge Biotech Corp. - Sep., p. 266, 269; Nov., p. 333; Dec., p. 364
Cangene Corp. - Dec., p. 366
Cantab Pharmaceuticals PLC - Oct., p. 301
Carrington Labs. Inc. - Aug., p. 236
CEL-SCI Corp. - Apr., p. 102; May, p. 140; Aug., p. 235; Oct., p. 299; Nov., p. 331
Cell Genesys, Inc. - Sep., p. 265; Nov., p. 328
Centers for Disease Control and Prevention (CDC) - Feb., p. 38, 43, 44; Mar., p. 65, 77; July, p. 204, 205; Aug., p. 236
Centocor, Inc. - July, p. 198
Cheil Foods and Chemicals, Inc. - Feb., p. 41
Chiron Corp. - Feb., p. 44; Mar., p. 70, 77; Apr., p. 98; May, p. 134, 141, 142; July, p. 202; Sep., p. 260, 270; Oct., p. 291, 292, 296; Nov., p. 335; Dec., p. 366
Chiron Vision Corp. - Feb., p. 39; Dec., p. 357
Collagen Corp. - Feb., p. 46
Columbia Laboratories, Inc. - July, p. 201
Commonwealth Serum Labs. - Feb., p. 41
Community Programs for Clinical Res. on AIDS (CPCRA) - Oct., p. 300
Community Research Initiative on AIDS - Apr., p. 105
Connaught Labs. (see also Pasteur-Merieux Group) - June, p. 164, 169; July, p. 196; Sep., p. 270
Corange Ltd. - Nov., p. 327
Corixa Corp. - Dec., p. 363
Cryopharm Corp. - Sep., p. 270
CSL Ltd. - Feb., p. 41
CW Group - Feb., p. 41
Cytel Corp. - Oct., p. 300; Nov., p. 330
CytoDyn, Inc. - Oct., p. 297
CytRx Corp. - Sep., p. 270; Nov., p. 335
Dana-Farber Cancer Inst. - May, p. 133, 134
District Court of The Hague - May, p. 141
Domain Associates - Feb., p. 41
Dow Chemical Co. - May, p. 139
DuPont Merck Pharmaceuticals - Mar., p. 72
Emisphere Technologies, Inc. - June, p. 169; Nov., p. 331
Epitope, Inc. - May, p. 142
Epoch Pharmaceuticals - Nov., p. 332
Food and Drug Administration (FDA) - Feb., p. 36, 37, 42, 43; Mar., p. 65, 67; May, p. 138, 140; July, p. 204; Aug., p. 225, 228, 230; Sep., p. 260, 266, 267; Nov., p. 321, 323, 324; Dec., p. 353, 364
Fujimoto Diagnostics, Inc. - Feb., p. 46
Gallo, R.C. - Feb., p. 42; June, p. 166
Genelabs Tech., Inc. - Feb., p. 38; Mar., p. 77; May, p. 142; Sep., p. 263
Genentech, Inc. - May, p. 139; Sep., p. 260
Genetic Therapy, Inc. - Apr., p. 107; July, p. 199
Genetics Institute - July, p. 200; Nov., p. 329
Genetics Systems - Sep., p. 269
Genta Inc. - Apr., p. 102
Georgetown Univ. Medical Center - Dec., p. 360
Getty, J. - Aug., p. 230
Gilead Sciences, Inc. - Feb., p. 38; May, p. 132, 133; Sep., p. 260; Oct., p. 292; Nov., p. 325
Glaxo PLC - Feb., p. 34, 35; Mar., p. 71
Glaxo Wellcome Co./Glaxo Wellcome PLC (see also Burroughs Wellcome) - Mar., p. 72, 76; Apr., p. 101, 103; May, p. 135, 140; June, p. 170, 171, 173; Aug., p. 225, 227, 233, 236; Sep., p. 257, 262, 266; Oct., p. 289; Nov., p. 321, 326; Dec., p. 356, 363, 365
Hanbro Group - May, p. 135
Harlan Sprague Dawley Inc. - Nov., p. 336
Harvard Medical School - May, p. 133
Harvard Univ. - May, p. 134; July, p. 194
Health Insurance Association of America - Sep., p. 266
HemaCare Corp. - Feb., p. 40
HemaSure Inc. - Nov., p. 331
Hoechst AG - May, p. 139; Nov., p. 328; Dec., p. 364
Hoechst Marion Roussel - Nov., p. 328
Hoffmann-La Roche AG - May, p. 139; July, p. 195; Oct., p. 289
Hoffmann-La Roche Inc. - Feb., p. 33, 39, 45; Mar., p. 72; Apr., p. 103; May, p. 139; June, p. 161; July, p. 202, 203; Aug., p. 235; Sep., p. 257, 264, 267, 267, 279; Oct., p. 290, 295, 298, 299; Nov., p. 323, 324, 329; Dec., p. 353, 357
Hospital San Jorge - Oct., p. 296
Houghton Pharmaceuticals, Inc. - May, p. 140; Sep., p. 268
Hybridon Inc. - Feb., p. 41
ICN Pharmaceuticals Inc. - Mar., p. 75; Aug., p. 234
IDT, Inc. - May, p. 138
Immune Response Corp. - Feb., p. 37; Mar., p. 74; June, p. 170; Oct., p. 298
Immuno AG - May, p. 137
Immusol, Inc. - Mar., p. 76; Apr., p. 99
Indiana Univ. - Sep., p. 268
Institut National de Transfusion Sanguine - July, p. 198
Institut Pasteur - May, p. 136; Sep., p. 269
Institute of Human Virology - June, p. 166; Dec., p. 358
Institute of Medicine, NAS - Mar., p. 76; May, p. 140
Inter-Company Collaboration for AIDS Drug Development (ICC) - Apr., p. 103; Dec., p. 363
Interferon Sciences, Inc. - Feb., p. 46; May, p. 139; June, p. 169; Dec., p. 360
International Agency for Research on Cancer (IARC) - June, p. 163
International Biological Study on Cervical Cancer (IBSCC) - June, p. 163
International Murex Technologies Corp. - May, p. 141; Dec., p. 366
Intracel Corp. - Sep., p. 267
Isis Pharmaceuticals, Inc. - May, p. 131; Oct., p. 293; Nov., p. 335
Ivax Corp. - Feb., p. 42
Jagotec AG - Apr., p. 102
Japan Energy - Mar., p. 72
Japan Tobacco Inc. - May, p. 137; Sep., p. 266
Jefferson Medical College - Sep., p. 268
Johnson & Johnson Co. (see Ortho Diagnostic Systems)
Karolinska Inst. - July, p. 198
Kissei Pharmaceutical Co., Ltd. - Mar., p. 72; May, p. 140
Kleiner Perkins Caulfield and Byers - Feb., p. 41
Lederle-Praxis Biologicals - Sep., p. 262
Lehigh Univ. - Sep., p. 270
LIDAK Pharmaceuticals - May, p. 137, 138; Oct., p. 293
Liposome Co., The - Apr., p. 109
LXR Biotechnology Inc. - Nov., p. 333
Marion Merrell Dow Inc. - May, p. 139
Massachusetts General Hospital - Oct., p. 300
Matrix Pharmaceutical, Inc. - Feb., p. 46; Sep., p. 264; Dec., p. 364
Medeva PLC - Nov., p. 335
MediChem Research Inc. - Oct., p. 300
MedImmune, Inc. - Apr., p. 97; June, p. 165, 168; Aug., p. 228; Nov., p. 327, 335; Dec., p. 360, 364
Memorial Sloan Kettering Cancer Center - Sep., p. 279
Merck & Co. - Feb., p. 41; Mar., p. 65, 72, 73; Apr., p. 104; May, p. 129; July, p. 203, 204; Aug., p. 233; Oct., p. 291, 298
Michigan Dept. of Public Health - Sep., p. 267
MicroGeneSys, Inc. - June, p. 164
MicroProbe Corp. - Nov., p. 332
Mitotix Inc. - Apr., p. 103
Myco Pharmaceuticals - Apr., p. 99
N.P.O. Vector - Dec., p. 361
National Academy of Sciences (NAS) - Mar., p. 76; May, p. 140
National Cancer Advisory Board - June, p. 172
National Cancer Inst. (NCI) - Mar., p. 72; June, p. 172, 173; July, p. 205; Aug., p. 238; Dec., p. 358, 366
National Cooperative Drug Discovery Groups (NCDDG) - May, p. 134
National Heart, Lung and Blood Inst. (NHLBI) - Apr., p. 97
National Institute of Allergy and Infectious Diseases (NIAID) - Feb., p. 42; Mar., p. 70, 77; Apr., p. 100, 108; June, p. 172; Oct., p. 300; Dec., p. 363, 364
National Institute of Dental Research (NIDR) - May, p. 136
National Institute of Mental Health (NIMH) - Nov., p. 329
National Institutes of Health (NIH) - Feb., p. 42, 46; Apr., p. 106, 107, 109; June, p. 165, 173; July, p. 202
New York Univ. Medical Center, - Oct., p. 294
Nippon Zeon Ltd. - May, p. 140
North American Biologicals, Inc. - Sep., p. 260, 267
Novopharm, Inc. - June, p. 173
Oclassen Pharmaceuticals Inc. - Apr., p. 105
Oncologix, Inc. - Mar., p. 75
OncorPharm Inc. - July, p. 206
OncoRx Inc. - Nov., p. 334
OraVax, Inc. - Oct., p. 294
Ortho Diagnostics Systems, Inc. - Feb., p. 44; Mar., p. 77; May, p. 142; Sep., p. 263, 266; Nov., p. 335
Oxford Asymmetry - Apr., p. 99
Oxford Bioscience Partners - Feb., p. 41; Apr., p. 109
Paracelsian, Inc. - July, p. 202; Dec., p. 366
PAREXEL International Inc. - Apr., p. 103
Pasteur Sanofi Diagnostics - Sep., p. 269
Pasteur-Merieux Group - June, p. 164, 169; July, p. 196; Sep., p. 270
PathoGenesis Corp. - May, p. 135
Paul Ehrlich Institute - Dec., p. 358
Peptech (USA) - Nov., p. 329
Pfizer Inc. - Mar., p. 76; Apr., p. 99; Oct., p. 301
Pharma Bio-Research - May, p. 139
Pharma Mar S.A. - May, p. 136; Aug., p. 236
Pharmacia AB - Feb., p. 41; Sep., p. 265
Princeton University - July, p. 206
Procept, Inc. - May, p. 134
Progenics Pharmaceuticals, Inc. - June, p. 166; Nov., p. 333; Dec., p. 364
Promega Corp. - Feb., p. 45
Protein Design Labs. Inc. - Nov., p. 327
Purdue Frederick Co. - May, p. 139
Rhein Biotech AG - June, p. 171
Rhone-Poulenc Rorer Inc. - Mar., p. 74; Nov., p. 330
Rhone-Poulenc Rorer S.A. - July, p. 196; Sep., p. 270
RiboGene, Inc. - Feb., p. 41; May, p. 140; Sep., p. 268
RPR Gencell - Nov., p. 330
San Raffaele Scientific Institute - Dec., p. 358
Sandoz Ltd. - July, p. 199
Sang-A - May, p. 135
Schering-Plough Corp. - May, p. 135; Aug., p. 234
SciClone Pharmaceuticals, Inc. - Feb., p. 41; June, p. 171
Scripps Research Inst., The - Nov., p. 330
Senegal - July, p. 194
Sepracor Inc. - Nov., p. 331
Sequel Therapeutics Inc. - Nov., p. 330
Serono Labs., Inc. - Feb., p. 42
Shaman Pharmaceuticals, Inc. - June, p. 162
Sheffield Medical Technologies Inc. - Aug., p. 235
Sierra Ventures - Feb., p. 41
SmithKline Beecham Biologicals - Mar., p. 67; Oct., p. 299; Dec., p. 363
SmithKline Beecham Corp. - Apr., p. 109; May, p. 138, 142; Oct., p. 297, 302; Dec., p. 355
Somatix Therapy Corp. - Apr., p. 107
Southern Research Inst. - Sep., p. 268
Southwest Foundation for Biomedical Research - Dec., p. 364
SRA Technologies - Sep., p. 268
Strategic Program for Innovative Research on AIDS Treatment (SPIRAT) - Aug., p. 231; Oct., p. 300
Synergen, Inc. - May, p. 136
Syntex Corp. - Feb., p. 33, 39; May, p. 139
T Cell Diagnostics Inc. - July, p. 204
Tanox Biosystems, Inc. - July, p. 197; Sep., p. 268
Terrapin Technologies Inc. - Apr., p. 109
Terry Beirn Community Programs for Clinical Res. on AIDS - Oct., p. 300
Therapeutic Peptides Inc. - Nov., p. 329
Theratechnologies Inc. - Nov., p. 336
Trimeris Inc. - Oct., p. 300
Trinity Medical Group - Oct., p. 298
Triplex Pharmaceutical Corp. - Mar., p. 75
Tulane Univ. - Sep., p. 269; Oct., p. 302
UniQuest Ltd. - Feb., p. 41
United Biomedical Inc. - June, p. 170
Univax Biologics, Inc. - Sep., p. 260; Oct., p. 292
Univ. of Alabama - Feb., p. 41; Nov., p. 333
Univ. of California (San Francisco, CA) - May, p. 133; Aug., p. 230
Univ. of California (Santa Barbara, CA) - June, p. 171
Univ. of Maryland - June, p. 166
Univ. of Medicine and Dentistry of New Jersey - Sep., p. 270; Dec., p.358
Univ. of Oklahoma - Dec., p. 364
Univ. of Pennsylvania - Aug., p. 231; Oct., p. 298
Univ. of Pittsburgh - Aug., p. 230; Nov., p. 333; Dec., p. 364
Univ. of Puerto Rico - Nov., p. 333; Dec., p. 364
Univ. of Rochester - Nov., p. 335; Dec., p. 360
Univ. of Washington - Sep., p. 268
Upjohn Co. - Mar., p. 72; Sep., p. 265
U.S. Army Medical Command - July, p. 205
U.S. Army Medical Research Inst. of Infectious Diseases - Dec., p. 361
U.S. Bioscience, Inc. - Feb., p. 46
U.S. Department of Health and Human Services (DHHS) - Feb., p. 44
U.S. House of Representatives Commerce Committee - Feb., p. 42
U.S. Justice Department - June, p. 173
U.S. Patent and Trademark Office - Feb., p. 45; Mar., p. 78; Aug., p. 239
U.S. Supreme Court - June, p. 173
Vaxcel, Inc. - Sep., p. 270; Nov., p. 335
Verex Laboratories, Inc. - Dec., p. 365
Vertex Pharm. - Mar., p. 72; May, p. 140; Aug., p. 233; Dec., p. 356
Viagene, Inc. - Feb., p. 46; Apr., p. 98; Sep., p. 270; Oct., p. 296
VIMRx Pharmaceuticals Inc. - Apr., p. 104; May, p. 139
Viral Technologies, Inc. - Apr., p. 102; May, p. 140; Aug., p. 235; Oct., p. 299; Dec., p. 364
Viral Therapeutics Inc. - Oct., p. 302; Dec., p. 364
Virex Inc. - June, p. 166
Virginia Commonwealth Univ. - Nov., p. 328
Virion Systems, Inc. - Sep., p. 268
Virogenetics Corp. - June, p. 164
Walter Reed Army Inst. of Research (WRAIR) - July, p. 203
Warner-Lambert Co - Feb., p. 36, 41; Dec., p. 363
Warner-Lambert Consumer Healthcare - Dec., p. 363
Weizman Inst. of Science - Sep., p. 265
Wellcome PLC (see also Glaxo Wellcome) - Feb., p. 34; Mar., p. 71
Wellcome Trust - Feb., p. 34
Whitehead Inst. - Apr., p. 107
Wistar Inst. - Oct., p. 298; Nov., p. 329
Wyeth-Ayerst Labs. - Apr., p. 100, 109; Nov., p. 327; Dec., p. 361
Xenograft Technologies, Ltd. - Sep., p. 265
XTL Biopharmaceuticals - Sep., p. 265
Yamanouchi Europe B.V. - Oct., p. 293
Yerkes Regional Primate Research Center - Nov., p. 331
Zeneca Pharmaceuticals - Mar., p. 71
Zynaxis Inc. - Sep., p. 267; Dec., p. 364